AA, T., S, N., MD, S., JW, G., B, J., F, B., . . . J, K. (2024). Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 30(2), 266. https://doi.org/10.1177/13524585231225855
Chicago Style (17th ed.) CitationAA, Toorop, et al. "Exploring the Effects of Extended Interval Dosing of Natalizumab and Drug Concentrations on Brain Atrophy in Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England) 30, no. 2 (2024): 266. https://doi.org/10.1177/13524585231225855.
MLA (9th ed.) CitationAA, Toorop, et al. "Exploring the Effects of Extended Interval Dosing of Natalizumab and Drug Concentrations on Brain Atrophy in Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 30, no. 2, 2024, p. 266, https://doi.org/10.1177/13524585231225855.